For the Inventor, By the Inventor

Enter assignee name

Abingdon, United Kingdom

Ipsen Bioinnovation Limited

USPTO Granted Patents = 27

CIPO Patents = 4

EPO Patents = 21

Forward Citations = 146

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Keith Foster (9 out of 49 patents)

Andreas Rummel (8 out of 12 patents)

Gavin Stephen Hackett (7 out of 8 patents)

4. Sai Man Liu (7 out of 7 patents)

5. John Andrew Chaddock (7 out of 41 patents)

6. Dina Brady Anderson (5 out of 6 patents)

7. Philip Marks (5 out of 26 patents)

8. Lance Steward (4 out of 102 patents)

9. Joseph Francis (4 out of 51 patents)

10. Kei Roger Aoki (3 out of 126 patents)

11. Tanja Weil (3 out of 9 patents)

12. Aleksandrs Gutcaits (3 out of 8 patents)

13. Frederic Madec (3 out of 3 patents)

14. Shilpa Palan (2 out of 3 patents)

15. Elaine Harper (2 out of 3 patents)

27 patents: Sort by Forward Citations

1. 12037369 - Cationic neurotoxins (2024-07-16),

2. 11642399 - Composition comprising recombinant clostridium neurotoxin (2023-05-09),

3. 11441141 - Methods for the manufacture of proteolytically processed polypeptides (2022-09-13),

4. 11248219 - Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins (2022-02-15),

5. 11034947 - Cationic neurotoxins (2021-06-15),

6. 11014968 - Cationic neurotoxins (2021-05-25),

7. 10883096 - Carrier for targeting nerve cells (2021-01-05),

8. 10808236 - Methods for the manufacture of proteolytically processed polypeptides (2020-10-20),

9. 10744190 - Method for suppressing spasmodic torticollis (2020-08-18),

10. 10647750 - Cationic neurotoxins (2020-05-12),

11. 10619146 - Non-cytotoxic protein conjugates (2020-04-14),

12. 10550377 - Suppression of prostate cancer using a targeted clostridial neurotoxin (2020-02-04),

13. 10307468 - [object Object] (2019-06-04),

14. 10266816 - Carrier for targeting nerve cells (2019-04-23),

15. 10240138 - Polypeptides that bind to and inhibit secretion from growth hormone secreting cells (2019-03-26),

Ipsen Bioinnovation Limited is a biotechnology company specializing in discovering and developing innovative biopharmaceutical products. With a focus on innovative therapies for rare diseases, our team of researchers and scientists are dedicated to advancing medical science and improving patients' lives. Visit our website to learn more about our company, products, and ongoing research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

27 Patents

#8 in Abingdon

#656 in United Kingdom

#23,293 in the World

Abingdon, United Kingdom

Ipsen Bioinnovation Limited

Forward Citations = 146

23 inventors:

Keith Foster (9 out of 49 patents)

Andreas Rummel (8 out of 12 patents)

Gavin Stephen Hackett (7 out of 8 patents)

4. Sai Man Liu (7 out of 7 patents)

5. John Andrew Chaddock (7 out of 41 patents)

Please report any incorrect information to support@idiyas.com

Loading…